Tango Therapeutics stockholders approve officer liability limit and elect directors at 2024 annual meeting

Tango Therapeutics, Inc.

Shareholders approved amendment to Second Amended and Restated Certificate of Incorporation to limit officer liability under Delaware law (89.9M for, 5.5M against).
Elected Alexis Borisy, John Ketchum, and Barbara Weber as Class III directors each with >90M votes for.
Ratified PricewaterhouseCoopers as independent auditor for FY2024 (100.7M for, 2K against).
Quorum of 94.35% (100.7M shares) present at virtual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.